Identification of the oxidative stress proteome in the brain

Free Radical Biology and Medicine

Volumn 50, Issue 4, 2011, Pages 487-494

  Sultana, Rukhsana ^a,b   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

3 Nitrotyrosine; Mass spectrometry; Oxidative modification; Protein carbonyls; Protein bound HNE; Redox proteomics; Two dimensional gel electrophoresis

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; PROTEIN; PROTEOME;

ARTICLE; BRAIN; ELECTROSPRAY MASS SPECTROMETRY; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PEPTIDE MASS FINGERPRINTING; PRIORITY JOURNAL; PROTEIN BLOTTING; PROTEIN CARBONYLATION; PROTEIN DATABASE; PROTEIN ELECTROPHORESIS; PROTEIN MODIFICATION; PROTEOMICS; STAINING; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 79251617521     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.11.021     Document Type: Short Survey

References (59)

1. P.H. O'Farrell High resolution two-dimensional electrophoresis of proteins J. Biol. Chem. 250 1975 4007 4021
2. T. Rabilloud Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains Proteomics 2 2002 3 10
3. M.B. Smolka, H. Zhou, S. Purkayastha, and R. Aebersold Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis Anal. Biochem. 297 2001 25 31
4. Y. Wagner, A. Sickmann, H.E. Meyer, and G. Daum Multidimensional nano-HPLC for analysis of protein complexes J. Am. Soc. Mass Spectrom. 14 2003 1003 1011
5. N.L. Anderson, A.D. Matheson, and S. Steiner Proteomics: applications in basic and applied biology Curr. Opin. Biotechnol. 11 2000 408 412
6. R. Aebersold, and D.R. Goodlett Mass spectrometry in proteomics Chem. Rev. 101 2001 269 295
7. I. Dalle-Donne, A. Scaloni, and D.A. Butterfield Redox Proteomics: from Protein Modifications to Cellular Dysfunction and Diseases 2006 Wiley Hoboken
8. D.A. Butterfield Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain Free Radic. Res. 36 2002 1307 1313
9. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress Free Radic. Biol. Med. 32 2002 1050 1060
10. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401
11. M.A. Lovell, S.P. Gabbita, and W.R. Markesbery Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF J. Neurochem. 72 1999 771 776
12. M.A. Lovell, and W.R. Markesbery Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid Arch. Neurol. 58 2001 392 396
13. W.R. Markesbery, R.J. Kryscio, M.A. Lovell, and J.D. Morrow Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment Ann. Neurol. 58 2005 730 735
14. M.A. Smith, P.L. Richey Harris, L.M. Sayre, J.S. Beckman, and G. Perry Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 1997 2653 2657
15. M.A. Smith, P.L. Richey, S. Taneda, R.K. Kutty, L.M. Sayre, and V.M. Monnier Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease Ann. NY Acad. Sci. 738 1994 447 454
16. R. Sultana, M. Perluigi, and D.A. Butterfield Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42) J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 833 2006 3 11
17. R. Sultana, H.F. Poon, J. Cai, W.M. Pierce, M. Merchant, and J.B. Klein Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach Neurobiol. Dis. 22 2006 76 87
18. J. Shen, X. Yang, A. Dong, R.M. Petters, Y.W. Peng, and F. Wong Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa J. Cell. Physiol. 203 2005 457 464
19. D.A. Butterfield, and E.R. Stadtman Protein oxidation processes in aging brain Adv. Cell Aging Gerontol. 2 1997 161 191
20. B.S. Berlett, and E.R. Stadtman Protein oxidation in aging, disease, and oxidative stress J. Biol. Chem. 272 1997 20313 20316
21. I. Dalle-Donne, A. Scaloni, D. Giustarini, E. Cavarra, G. Tell, and G. Lungarella Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics Mass Spectrom. Rev. 24 2005 55 99
22. E.R. Stadtman, and R.L. Levine Free radical-mediated oxidation of free amino acids and amino acid residues in proteins Amino Acids 25 2003 207 218
23. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am. J. Physiol. 271 1996 C1424 1437
24. M.F. Beal Mitochondrial dysfunction in neurodegenerative diseases Biochim. Biophys. Acta 1366 1998 211 223
25. T. Koeck, B. Levison, S.L. Hazen, J.W. Crabb, D.J. Stuehr, and K.S. Aulak Tyrosine nitration impairs mammalian aldolase A activity Mol. Cell. Proteomics 3 2004 548 557
26. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
27. S. Choudhary, W. Zhang, F. Zhou, G.A. Campbell, L.L. Chan, and E.B. Thompson Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells Free Radic. Biol. Med. 32 2002 360 369
28. M. Hashimoto, T. Sibata, H. Wasada, S. Toyokuni, and K. Uchida Structural basis of protein-bound endogenous aldehydes: chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct J. Biol. Chem. 278 2003 5044 5051
29. W.R. Markesbery, and M.A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol. Aging 19 1998 33 36
30. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK Exp. Neurol. 180 2003 144 155
31. K. Uchida 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress Prog. Lipid Res. 42 2003 318 343
32. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, and W.R. Markesbery The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42 J. Neurochem. 78 2001 413 416
33. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, and G. Waeg The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins J. Neurochem. 69 1997 1161 1169
34. J.B. Owen, R. Sultana, C.D. Aluise, M.A. Erickson, T.O. Price, and G. Bu Oxidative modification to LDL-related receptor protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain Free Radic. Biol. Med. 49 2010 1798 1803
35. M. Perluigi, R. Sultana, G. Cenini, F. Di Domenico, M. Memo, and W.M. Pierce Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis Proteomics Clin. Appl. 3 2009 682 693
36. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, and W.M. Pierce Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic. Biol. Med. 33 2002 562 571
37. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, and R. Booze Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
38. D.A. Butterfield, H.F. Poon, D. St Clair, J.N. Keller, W.M. Pierce, and J.B. Klein Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease Neurobiol. Dis. 22 2006 223 232
39. M. Perluigi, H.F. Poon, W. Maragos, W.M. Pierce, J.B. Klein, and V. Calabrese Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease Mol. Cell. Proteomics 4 2005 1849 1861
40. H.F. Poon, M. Frasier, N. Shreve, V. Calabrese, B. Wolozin, and D.A. Butterfield Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice-a model of familial Parkinson's disease Neurobiol. Dis. 18 2005 492 498
41. H.F. Poon, K. Hensley, V. Thongboonkerd, M.L. Merchant, B.C. Lynn, and W.M. Pierce Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis Free Radic. Biol. Med. 39 2005 453 462 (Pubitemid 41021644)
42. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, and J.B. Klein Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD Neurobiol. Aging 27 2006 1564 1576
43. J. Choi, A.I. Levey, S.T. Weintraub, H.D. Rees, M. Gearing, and L.S. Chin Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J. Biol. Chem. 279 2004 13256 13264
44. S.F. Newman, R. Sultana, M. Perluigi, R. Coccia, J. Cai, and W.M. Pierce An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach J. Neurosci. Res. 85 2007 1506 1514
45. M.A. Lovell, W.D. Ehmann, S.M. Butler, and W.R. Markesbery Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease Neurology 45 1995 1594 1601
46. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, and R.A. Floyd Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease Proc. Natl. Acad. Sci. USA 88 1991 10540 10543
47. M. Balastik, J. Lim, L. Pastorino, and K.P. Lu Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism? Biochim. Biophys. Acta 1772 2007 422 429
48. M.A. Korolainen, T.A. Nyman, P. Nyyssonen, E.S. Hartikainen, and T. Pirttila Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease Clin. Chem. 53 2007 657 665
49. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.D. Yan, and D. Stern Advanced Maillard reaction end products are associated with Alzheimer disease pathology Proc. Natl. Acad. Sci. USA 91 1994 5710 5714
50. Q. Wang, R.L. Woltjer, P.J. Cimino, C. Pan, K.S. Montine, and J. Zhang Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein FASEB J. 19 2005 869 871
51. B.A. Soreghan, F. Yang, S.N. Thomas, J. Hsu, and A.J. Yang High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain Pharm. Res. 20 2003 1713 1720
52. M.J. MacCoss, and J.R. Yates III Proteomics: analytical tools and techniques Curr. Opin. Clin. Nutr. Metab. Care 4 2001 369 375
53. R.C. Beavis, and B.T. Chait Cinnamic acid derivatives as matrices for ultraviolet laser desorption mass spectrometry of proteins Rapid Commun. Mass Spectrom. 3 1989 432 435
54. D.A. Butterfield, D. Boyd-Kimball, and A. Castegna Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration J. Neurochem. 86 2003 1313 1327 (Pubitemid 37174249)
55. H.F. Poon, A. Castegna, S.A. Farr, V. Thongboonkerd, B.C. Lynn, and W.A. Banks Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain Neuroscience 126 2004 915 926
56. V. Thongboonkerd, J. Luengpailin, J. Cao, W.M. Pierce, J. Cai, and J.B. Klein Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors J. Biol. Chem. 277 2002 16599 16605
57. D.N. Perkins, D.J. Pappin, D.M. Creasy, and J.S. Cottrell Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 1999 3551 3567
58. J.R. Yates III, J.K. Eng, A.L. McCormack, and D. Schieltz Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database Anal. Chem. 67 1995 1426 1436
59. M. Fountoulakis, and B. Takacs Effect of strong detergents and chaotropes on the detection of proteins in two-dimensional gels Electrophoresis 22 2001 1593 1602